Postdoc fellowship
- KRE, Translational Research Unit, Section of Cellular Therapy, Oslo University Hospital- (in new tab)
- About the position
A postdoctoral fellowship in the field of cancer immunotherapy to work on “Safety-Enhanced Chimeric Antigen Receptors (SECAR)” will be available for a period of 30 months starting from November 2025. This postdoctoral fellowship is funded by Helse Sør -Øst.Key information
- Application deadline:
** **
- Employer:
**Oslo universitetssykehus HF**
- Town/city:
**Oslo**
- Title:
**Postdoc fellowship**
- Positions:
**1**
- Full-time/part-time:
**Full-time**
- Employment type:
**Contract**
- Percentage of full-time:
**100**
- Webcruiter ID:
** **
- Start date:
** **
- Social sharing:
- Share on x- Share on LinkedIn- Share on Facebook- Project description
- Chimeric Antigen Receptor (CAR) molecules have shown outstanding therapeutic effects for the treatment of otherwise fat...